Pharmaceutical companies operate in a healthcare market that has become more complex and in which pure one-way product communication is no longer attractive. Self-confident doctors and the “informed patient” type are no longer passive target groups or customers, but demand a more active role in the market for medical products and services.
Patient participation, the demand for evidence data on the medical benefit of a therapeutic and shared value approaches in product development and therapy decisions are current trends that pharmaceutical companies must integrate into their communication strategies.
We support you across the entire spectrum from product to stakeholder communication with our medical-scientific know-how and our insight into the dynamic changes in the healthcare market.
